Alex Dickinson

Alex Dickinson is a seasoned executive and entrepreneur with extensive experience in healthcare, life sciences, and information technology. He currently serves as the Chair of Ryght, a California-based company he co-founded that applies generative AI to clinical trials.15

Professional Background

Current Roles::

• Chair at Ryght4
• Chairman of the Board at BC Platforms (appointed in July 2024)1
• Board member of Chromacode, a cloud-based molecular diagnostics company1
• Board member of Gencove, an NGS analytics software platform provider1

Previous Experience::

• SVP Strategic Initiatives at Illumina (2010-2017), where he led the company's nation-scale precision medicine program and cloud computing efforts1
• CEO and co-founder of Helixis, acquired by Illumina in 20101
• CEO and co-founder of Luxtera (2001-2007), later acquired by Cisco Systems for $660M1

Education and Expertise

Alex Dickinson holds a PhD in Electrical Engineering from the University of Adelaide and an MBA from Columbia Business School in New York.1 He is known for his expertise in:

• Precision medicine technology
• Healthcare data management and analytics
• Generative AI applications in healthcare
• Cloud computing and bioinformatics
• Mergers and acquisitions in the life sciences sector

Recent Appointments

In July 2024, Dickinson was appointed as the new Chairman of the Board at BC Platforms, a global leader in real-world data, healthcare data management, and analytics.1 His role at BC Platforms involves driving the company's strategic agenda and leveraging his experience in M&A and precision medicine to accelerate the company's growth as a global technology enabler for real-world data.1

Alex Dickinson is actively involved in the healthcare technology sector, particularly in companies leveraging AI and advanced analytics for clinical research and drug development. His LinkedIn profile (username: alexgdickinson) provides insights into his professional activities and thoughts on industry developments.23